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Importance 
Anthrax is a serious zoonotic disease that can affect most mammals and several 
species of birds, but is particularly important in herbivores. This disease is caused by 
a spore-forming bacterium, Bacillus anthracis. Anthrax spores are extremely resistant 
to inactivation by heat or chemicals, and can survive in the environment for decades. 
Susceptibility to clinical disease varies, with domesticated and wild ruminants most 
susceptible, horses somewhat less susceptible, and omnivores and carnivores 
relatively resistant. In endemic regions, anthrax can be a serious problem in 
unvaccinated ruminants. Although antibiotics may be effective if started early, the 
course of disease is usually rapid in these animals, and symptomatic infections are 
often fatal. Epizootics in wildlife are also a concern. In 2004, an outbreak in the 
Malilangwe Wildlife Reserve in Zimbabwe killed almost all of the approximately 500 
kudu in the reserve, as well as large numbers of other wild ruminants.  
Human cases usually develop after exposure to infected animals and their 
tissues. In most countries, human anthrax occurs infrequently and sporadically, 
mainly as an occupational hazard among veterinarians, agricultural workers and 
workers who process hides, hair, wool and bone products. In humans, the three 
forms of anthrax are cutaneous, gastrointestinal and inhalational. Cutaneous anthrax 
accounts for more than 95% of natural infections, and is rarely fatal if treated with 
antibiotics. The gastrointestinal form is less common but more serious, and can 
occur in outbreaks associated with contaminated meat. Inhalational anthrax is the 
most serious form, and has a very high case fatality rate even when treated. Natural 
cases of inhalational anthrax are rare; however, anthrax has been used as a weapon 
by bioterrorists, and weaponized anthrax can form aerosols readily. In 2001, 
weaponized anthrax was delivered in letters through the United States mail, 
resulting in 11 cases of inhalational anthrax and 11 cases of cutaneous anthrax. Five 
people with inhalational anthrax died. Because ruminants are particularly sensitive 
to anthrax, widespread disease in animals might serve as an early warning of a 
bioterrorist attack under some circumstances. 
Etiology 
Anthrax results from infection by Bacillus anthracis, a spore forming, Gram 
positive aerobic rod in the family Bacillaceae. Fully virulent B. anthracis isolates 
have two plasmids: pX01, which codes for a tripartite protein exotoxin complex, and 
pX02, which encodes the capsule genes. B. anthracis is genetically very 
homogeneous; however, researchers have identified several genetically distinct 
groups that appear to be derived from clones. Some of these clones are distributed 
worldwide, while others are found in limited geographic areas.  
B. anthracis is a member of the Bacillus cereus group, which also contains B. cereus 
and Bacillus thuringiensis. These three organisms are very closely related. Based on 
genetic analysis, some authors consider them to be a single species; however, this idea is 
controversial. Plasmids closely related to pX01 and/or pX02 have recently been found in a 
few B. cereus isolates that caused anthrax-like diseases in people, chimpanzees or gorillas. 
Geographic Distribution 
Although B. anthracis can be found worldwide, anthrax cases usually occur only 
in limited geographic regions. Outbreaks are most common in areas characterized by 
alkaline, calcareous soil, a warm environment, and periodic episodes of flooding. 
Anthrax is particularly common in parts of Africa, Asia and the Middle East. In the 
United States, this disease has been reported from most states, but it occurs most often 
in the Midwest and West. Endemic foci are currently located in the Dakotas, Texas, 
northwest Minnesota and Nevada, with smaller areas in other U.S. states. 
Transmission 
In animals, transmission occurs by ingestion and possibly inhalation of spores, 
although entry through skin lesions has not been ruled out. Herbivores usually become 
infected when they ingest sufficient numbers of spores in soil or on plants in pastures. 
Outbreaks are often associated with heavy rainfall, flooding or drought. Contaminated  
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bone meal and other feed can also spread this disease. 
Carnivores usually become infected after eating contaminated 
meat. Vultures and flies may disseminate anthrax 
mechanically after feeding on carcasses. 
In infected animals, large numbers of bacteria are 
present in hemorrhagic exudates from the mouth, nose and 
anus. When they are exposed to oxygen, these bacteria form 
endospores and contaminate the soil. Sporulation also 
occurs if a carcass is opened; however, this process requires 
oxygen and does not occur inside a closed carcass. Anthrax 
spores can remain viable for decades in the soil or animal 
products such as dried or processed hides and wool. Spores 
can also survive for two years in water, 10 years in milk 
and up to 71 years on silk threads. Vegetative organisms are 
thought to be destroyed within a few days during the 
decomposition of unopened carcasses. 
Humans usually develop the cutaneous form of anthrax 
after skin contact with infected animal tissues such as hides, 
wool, bone meal and blood. Experiments in mice suggest that 
anthrax spores may germinate and enter the skin in abraded 
but not intact skin. Biting flies that feed on infected animals or 
carcasses may be able to transmit this form mechanically. 
Inhalational anthrax occurs after inhaling spores from animal 
products, laboratory cultures or other sources. Gastrointestinal 
anthrax results from the ingestion of raw or undercooked 
meat containing viable spores. 
Anthrax has been weaponized by a number of 
countries. This agent has been used by terrorists. 
Weaponized anthrax forms aerosols readily and is often 
inhaled, but cutaneous exposure or ingestion can also occur.  
Ecology 
The ecology of anthrax is controversial. B. anthracis 
has long been considered an “obligate pathogen.” Unlike 
other members of the genus Bacillus, which are 
saprophytes, B. anthracis is thought to multiply almost 
exclusively inside the body. In the environment, it may 
exist only as dormant spores. If this idea is correct, spores 
originally derived from carcasses are the only source of 
exposure for animals, although carnivores, rain and other 
agents can disperse the spores to other locations. Heavy 
rains, alternating with dry periods, may concentrate the 
spores and result in outbreaks among grazing animals. 
Alternatively, the “incubator hypothesis” suggests that 
anthrax spores can germinate and divide to a limited extent 
in the environment, if certain conditions are met. This is 
thought to increase the concentration of B. anthracis in 
“incubator areas,” where outbreaks then occur. Although 
the incubator hypothesis is controversial, B. anthracis 
spores were recently shown to germinate on and around the 
roots of grass in a simple plant/ soil system. Plasmid 
transfer between B. anthracis isolates was also described in 
this system. As of March 2007, spore germination on plant 
roots had not been described outside the laboratory. 
 
Disinfection 
Anthrax spores are resistant to heat, sunlight, drying 
and many disinfectants. They can be killed with 
formaldehyde or 2% glutaraldehyde; overnight soaking is 
recommended. A 10% NaOH or 5% formaldehyde solution 
can be used for stockyards, pens and other equipment. 
Sodium hypochlorite has also been recommended for some 
purposes. The sporicidal effectiveness of hypochlorite 
solutions varies with the pH and the concentration of free 
available chlorine. To become an effective sporicidal agent, 
household bleach must be diluted with water to increase the 
free available chlorine, and adjusted to pH 7. Prolonged 
contact is recommended. Gaseous sterilization can be 
accomplished with chlorine dioxide, formaldehyde gas and 
other methods, under specific conditions of humidity and 
temperature. Sterilization is also possible by heating to 
121°C (250°F) for at least 30 min. Gamma radiation has 
been used to decontaminate animal products, as well as 
mail from contaminated postal facilities. Exposed arms and 
hands can be washed with soap and hot water then 
immersed for one minute in a disinfectant such as an 
organic iodine solution or 1 p.p.m. solution of mercuric 
perchloride. Clothing should be cleaned and boiled. 
There is little information on the time and temperatures 
needed to destroy B. anthracis spores in food; however, these 
spores are less resistant to heat inactivation than Clostridium 
botulinum spores, and methods to kill botulism spores are 
probably sufficient to destroy anthrax spores.  
Comprehensive information regarding the efficacy of 
specific sterilization methods for B. anthracis and other 
Bacillus species is available at 
http://www.cdc.gov/ncidod/eid/vol9no6/02-0377.htm. 
Disinfectant sensitivity information for B. anthracis is 
limited; however, a recent study suggests that 
decontamination data for solid surfaces can be extrapolated 
from closely related Bacillus species. 
Infections in Humans 
Incubation Period 
The incubation period in humans is usually 1 to 7 
days, but varies with the form of the disease. Typically, 
symptoms of cutaneous anthrax appear after 2 to 3 days. 
The incubation period for the gastrointestinal form is 
usually 2 to 5 days, but may be as short as 15 hours. In 
one outbreak, the mean incubation period for the 
oropharyngeal form of gastrointestinal anthrax was 42 
hours (range 2-144 hours). The incubation period for 
inhalational anthrax is highly variable. This disease can 
appear after two days, but spores may remain viable in the 
lungs for several weeks, and they can germinate and cause 
inhalational anthrax during that time. After accidental 
aerosol release in the Soviet Union, cases continued to 
appear for up to six weeks.  
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Clinical Signs 
Three forms of disease are seen in humans: cutaneous 
anthrax, gastrointestinal anthrax and inhalational anthrax.  
Cutaneous anthrax is characterized by a papular skin 
lesion, which becomes surrounded by a ring of fluid-filled 
vesicles. The central papule ulcerates, dries and develops a 
firmly adherent, depressed black scab. The skin lesion is 
usually painless, but it is often surrounded by significant 
edema. There may be regional lymphadenopathy. Swelling 
on the face or neck may occlude the airways. Lesions on the 
face or neck can also develop into meningitis. Fever, pus and 
pain are seen only if secondary infections occur. Cutaneous 
lesions often resolve spontaneously but disseminated, fatal 
infections occur in approximately 20% of cases. Small 
anthrax lesions usually heal with minimal scarring. 
Gastrointestinal anthrax develops after eating 
contaminated meat. When spores germinate in the intestinal 
tract, they cause ulcerative lesions. These lesions can occur 
anywhere and may, in severe cases, result in hemorrhage, 
obstruction or perforation. There is limited information on 
this form of anthrax, but reported cases range from 
asymptomatic infections to fatal disease. Gastrointestinal 
anthrax has been divided into two syndromes: abdominal 
and oropharyngeal anthrax. The initial symptoms of the 
abdominal form may be mild and can include malaise, a 
low fever and mild gastrointestinal symptoms such as 
nausea, vomiting, diarrhea and anorexia. This may be 
followed by the acute onset of severe gastrointestinal 
symptoms such as severe abdominal pain, hematemesis and 
bloody diarrhea. Massive ascites can also occur. In 
addition, there may be high fever, dyspnea, cyanosis, 
disorientation and other signs of septicemia. Severe 
gastrointestinal anthrax rapidly progresses to shock, coma 
and death. Abdominal anthrax may not always be severe. In 
an outbreak in Thailand, seven of 74 people with 
gastrointestinal anthrax had severe symptoms; acute 
diarrhea was the only symptom in the others. 
The oropharyngeal form is little known. The initial 
symptoms may include a sore throat, dysphagia, fever, 
hoarseness and swelling of the neck. The neck swelling is 
caused by edema and cervical lymphadenopathy, and can 
result in airway compromise. Mouth lesions have been 
reported on the tonsils, pharynx and hard palate. In one 
report, these lesions were initially edematous and congested. 
A central whitish area, caused by necrosis and ulceration, 
developed by the end of the first week. During the second 
week, a pseudomembrane developed over the ulcer. 
Inhalational anthrax occurs after inhaling spores. The 
clinical signs develop gradually and are nonspecific. Early 
symptoms may include fever, chills, tiredness and malaise; 
a nonproductive cough and mild chest pain may be present. 
The symptoms sometimes improve for several hours to 
three days. The prodromal period ends with the acute onset 
of severe respiratory distress, tachycardia, diaphoresis, 
stridor and cyanosis, followed by fatal septicemia and 
shock within one to two days. Hematogenous spread of B. 
anthracis can also cause gastrointestinal lesions and 
symptoms. 
Anthrax meningitis can be a complication of any of the 
other three forms of disease. After a prodromal period of 1-6 
days, typical signs of meningoencephalitis develop rapidly. 
Patients quickly lose consciousness and die, many within 24 
hours. Blood is often found in the cerebrospinal fluid. 
Communicability 
Person to person transmission of anthrax is extremely 
rare and has been reported only in cases of cutaneous 
anthrax. 
Diagnostic Tests 
Anthrax is often diagnosed by finding the characteristic 
organisms in clinical samples or by isolating B. anthracis in 
culture. Blood, fluid samples from skin lesions, aspirates of 
lymph nodes or spleen, ascitic fluid, pleural effusions or 
cerebrospinal fluid (in cases of meningitis) are stained with 
polychrome methylene blue (M’Fadyean’s stain). Using 
this stain, B. anthracis organisms are square-ended, blue-
black bacilli surrounded by a pink capsule. In a Gram stain, 
Bacillus anthracis is a large Gram positive rod that may 
occur singly, in pairs or in chains . Spores are not found in 
host tissues unless they have been exposed to air. 
B. anthracis colonies on blood agar are white or gray, 
flat, approximately 3-5 mm in diameter and nonhemolytic, 
with a rough, ground-glass appearance and a very tacky, 
butyrous consistency. Tails - wisps of growth trailing back 
toward the parent colony – may sometimes be seen; this 
characteristic has been described as a “medusa head” 
appearance. Unlike the other members of the B cereus 
group, B anthracis is non-motile. Capsules are not found 
when the this organism is grown aerobically in vitro, but 
may be demonstrated in mucoid colonies from cultures 
grown on nutrient agar with 0.7% sodium bicarbonate, 
incubated overnight under CO2. B. anthracis is also 
susceptible to specific bacteriophages (the gamma 
bacteriophage) and exhibits a characteristic ‘string–of–
pearls’ formation when grown with penicillin; however, the 
latter characteristics may be absent with some isolates. 
Antibiotic treatment of patients may prevent isolation of the 
organism. 
Polymerase chain reaction (PCR) techniques can also 
be used to identify B. anthracis. 
Antibodies develop late in the course of disease, and 
serology is only useful in retrospective studies. Both acute 
and convalescent sera must be taken. Serologic tests include 
enzyme linked immunosorbent assays (ELISAs) and other 
tests. Approximately 68-92% of patients with cutaneous 
anthrax develop antibodies to protective antigen or the 
capsule. A skin hypersensitivity test using AnthraxinT is 
used in some countries for retrospective diagnosis.  
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Treatment 
Natural strains of B. anthracis are usually susceptible 
to several antibiotics; most but not all natural strains are 
susceptible to penicillin. Some strains, particularly those 
used in bioterrorist attacks, may be resistant to penicillin. 
For this reason, the U.S. Centers for Disease Control and 
Prevention (CDC) recommends other antibiotics as the 
initial treatment, particularly for systemic disease, until 
antibiotic susceptibility has been determined. Antibiotics 
are effective only against the vegetative stage of B. 
anthracis, and not against spores. Treatment is continued 
for at least 60 days in inhalational anthrax, as spores may be 
able to remain dormant in the lungs and germinate during 
that time. Supportive therapy may also be necessary, 
particularly for the inhalational and gastrointestinal forms.  
Effective treatment depends on early recognition of the 
symptoms: treatment for cutaneous anthrax is usually 
effective, but the inhalational and gastrointestinal forms are 
difficult to recognize early and the mortality rates are higher.  
Prevention 
Humans can be protected by preventing disease in 
animals. Veterinary supervision of animal production and 
slaughter also helps prevent contact with infected livestock 
or animal products. Trade restrictions may be placed on 
certain animal products from countries where anthrax is 
common and uncontrolled. Improvements in industry 
standards have decreased the occupational risks for people 
exposed to imported hides, wool, bone meal, and other 
animal products. In laboratories, good safety practices, 
including the use of biological safety cabinets, should be 
employed. Veterinarians should use protective clothing and 
equipment when examining sick animals. They should also 
avoid opening the carcasses of suspected cases. Vaccines 
are available for humans at a high risk of infection. Human 
anthrax vaccines in the U.S. are based on an inactivated, 
cell-free extract of cultivated B anthracis. New vaccines are 
in development. 
Postexposure antibiotic prophylaxis is recommended for 
people who have been exposed to aerosolized anthrax spores. 
Treatment is continued for at least 60 days in inhalational 
anthrax, as spores may remain dormant in the lungs and 
germinate during that time. Simultaneous antibiotics and 
vaccination can be used in humans exposed to aerosols, as 
human anthrax vaccines are not live. Postexposure 
prophylaxis may also be needed for anyone who has eaten 
contaminated undercooked or raw meat. It is not generally 
recommended after cutaneous exposure; however, any 
exposed areas should be washed immediately, and the skin 
should be monitored for early signs of infection. 
Morbidity and Mortality 
Anthrax is still a significant risk in some countries, and 
outbreaks occasionally occur in humans. In Africa, 
estimates suggest that each cow with anthrax can result in 
up to ten human cases. However, the incidence of anthrax 
has declined sharply in developed nations. In the U.S., 
approximately 130 human cases occurred annually during 
the early 1900's, but only one or two cases of cutaneous 
anthrax are now generally seen in a year. In many countries, 
cases of anthrax occur infrequently and sporadically, 
mainly as an occupational hazard among veterinarians, 
agricultural workers, and workers who process hides, hair, 
wool and bone products.  
The cutaneous form accounts for at least 90-95% of 
natural anthrax infections. The gastrointestinal form seems 
to be uncommon, but can occur in outbreaks associated 
with contaminated meat. Natural cases of inhalational 
anthrax are rare; however, aerosolized biological weapons 
would be expected to produce a high percentage of this 
form. In 2001, 11 cases of inhalational anthrax and 11 cases 
of cutaneous anthrax were associated with a bioterrorist 
attack via anthrax-contaminated mail. 
The mortality rate varies with the form of the disease. 
Cutaneous anthrax is thought to be fatal in 5-20% of untreated 
cases, and less than 1% of patients treated with antibiotics. In 
contrast, the mortality rate is high for inhalational anthrax, 
even when treated appropriately. Earlier estimates suggested 
that the case-fatality rate for this form approached 90-100% 
but newer, more intensive treatment regiments may decrease 
the mortality rate. In the 2001 mail-associated bioterrorist 
attack, six of eleven patients with inhalational anthrax 
recovered with treatment (case fatality rate of 45%). However, 
once a patient reaches the fulminant stage, one study suggests 
that the mortality rate is 97% regardless of treatment. Anthrax 
meningoencephalitis is also deadly, with an estimated case 
fatality rate of 95-100%.  
Only limited information exists for gastrointestinal 
anthrax. The case fatality rate for the abdominal form is 
unknown, but it is estimated to be from 25% to 60-75%. 
Asymptomatic or mild infections have been described 
among adults in some outbreaks, with higher mortality rates 
in children. In one report from Uganda, gastroenteritis 
occurred in 134 of 155 people (92%) who ate meat from an 
infected zebu. Twelve adults remained asymptomatic. Nine 
deaths occurred, all in children. The remaining people were 
treated with antibiotics and rehydration therapy, and all 
recovered. The overall case fatality rate in this outbreak was 
7%. In Thailand, 28 cases of cutaneous anthrax and 74 
cases of gastrointestinal anthrax were reported in one 
outbreak. Seven people with gastrointestinal anthrax had 
severe symptoms; acute diarrhea was the only symptom in 
the remainder. Three patients died, for a case-fatality rate of 
4%. Reports of the oropharyngeal form of gastrointestinal 
anthrax are rare; however, published case fatality rates 
range from 12% during an outbreak in Thailand to 50% in a 
report from Turkey.  
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Infections in Animals 
Species Affected 
Virtually all mammals and some birds can contract 
anthrax, but susceptibility varies widely and most clinical 
cases occur in wild and domesticated herbivores. Cattle, 
sheep and goats are considered to be highly susceptible, and 
horses somewhat less so. Pigs, other omnivores and 
carnivores are more resistant to disease, but they may 
become ill if the dose is high. Birds are highly resistant. 
Incubation Period 
The incubation period varies from 1 to 20 days. In 
herbivores, infections become apparent after 3 to 7 days. 
The incubation period in pigs is usually 1 to 2 weeks. 
Clinical Signs 
In animals, anthrax can be a peracute, acute, subacute 
or chronic disease.  
In ruminants, peracute systemic disease is common, 
and sudden death may be the only sign. Staggering, 
trembling and dyspnea may be seen in some animals, 
followed by rapid collapse, terminal convulsions and death. 
In the acute form, clinical signs may be apparent for up to 2 
days before death. In this form, fever and excitement may 
be followed by depression, stupor, disorientation, muscle 
tremors, dyspnea and congested mucous membranes. 
Pregnant cows may abort, and milk production can drop 
severely. Bloody discharges from the nose, mouth and anus 
are sometimes seen. Occasionally, infections in ruminants 
are characterized by subcutaneous edematous swellings, 
most often in the ventral neck, thorax and shoulders 
Anthrax in wild herbivores varies with the species, but 
tends to resemble the disease in cattle. 
Horses typically develop acute disease. Common 
symptoms in this species include fever, chills, anorexia, 
depression, severe colic and bloody diarrhea. Swellings 
may be seen in the neck, sternum, lower abdomen and 
external genitalia. Dyspnea can occur due to the swelling of 
the neck. Affected animals usually die within 1 to 3 days 
but some animals can survive up to a week. 
Septicemia and sudden death occurs occasionally in 
pigs. More often, pigs have mild subacute to chronic 
infections characterized by localized swelling and systemic 
signs such as fever and enlarged lymph nodes. Some 
animals develop rapidly progressive swelling of the throat, 
with dyspnea and difficulty swallowing; these animals may 
suffocate. Intestinal involvement with anorexia, vomiting, 
diarrhea or constipation is less common. Some pigs with 
anthrax recover. Recovered, asymptomatic animals may 
have signs of localized infections in the tonsils and cervical 
lymph nodes at slaughter. 
Clinically apparent anthrax in dogs, cats and wild 
carnivores resemble the disease in pigs. A recent review of 
published cases in dogs suggests that massive swelling of the 
head, neck and mediastinum is the most common symptom in 
this species. In the published cases, death was usually the 
result of toxemia and shock, but swelling of the threat and 
suffocation could also have been a factor. Hemorrhagic 
gastroenteritis was reported in one dog, in addition to a 
swollen foreleg and ptyalism. Severe acute gastroenteritis has 
also been reported in other carnivores and omnivores. 
Communicability 
Large numbers of bacteria are present in the carcass 
and in bloody discharges from body openings. These 
bacteria can contaminate the environment or be a source of 
exposure for humans and other animals. Skin and wool can 
contain spores, which remain viable for long periods. 
Post Mortem Lesions      Click to view images 
Rigor mortis is usually absent or incomplete, and the 
carcass is typically bloated and decomposes rapidly. Dark, 
tarry blood may ooze from the body orifices; some sources 
suggest this is not a common sign. Edema may be noted, 
particularly around the throat and neck, in horses. 
Necropsies should be avoided, to prevent contamination 
of the surrounding area with spores.  
If a ruminant carcass is opened, signs of septicemia 
will be evident. The blood is dark, thick and does not clot 
readily. Edematous, blood-tinged effusions may be seen in 
the subcutaneous tissues, between skeletal muscles and 
under the serosa of organs. Petechiae and ecchymoses are 
often noted in the lymph nodes, the serosal surfaces of the 
abdomen and thorax, and the epicardium and endocardium. 
Hemorrhages and ulcers are also common in the intestinal 
mucosa; ulcers occur most often over Peyer’s patches, but 
can also be found in other locations. Peritonitis and 
excessive peritoneal fluid may be noted. The spleen is 
usually enlarged and has a ‘blackberry jam’ consistency. 
The lymph nodes, liver and kidneys may be swollen and 
congested. Meningitis can also occur. Similar internal 
lesions can be seen in some horses; in others, the lesions 
may be limited to edema of the neck and throat. 
Septicemic lesions may also be found in omnivores and 
carnivores, but are less common than edema and 
inflammation of the pharyngeal area, or gastrointestinal 
lesions. Pigs with chronic anthrax usually have lesions only 
in the pharyngeal area. The tonsils and cervical lymph 
nodes are typically enlarged and have a mottled salmon to 
brick-red color on cut surface. The tonsils may be covered 
by diphtheritic membranes or ulcers. The pharynx is usually 
edematous. A chronic intestinal form, with inflammation 
and lesions in the mesenteric lymph nodes, is also reported 
in pigs. Severe gastrointestinal inflammation, sometimes 
accompanied by hemorrhages and necrosis, has been 
reported in some omnivores and carnivores. Peritonitis can 
also occur. 
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Diagnostic Tests 
A presumptive diagnosis can be made if the 
characteristic bacteria are found in blood or other tissues. 
Blood clots poorly in anthrax, and samples may be obtained 
by making a small cut in an ear vein or with a syringe from 
any available vein. In pigs, bacteremia is rare and a small 
piece of aseptically collected, affected lymphatic tissue is 
often used. Tissue aspirates and pharyngeal swabs have 
been examined in some animals. Air-dried, fixed smears 
should be stained with polychrome methylene blue 
(M’Fadyean’s stain) or Giemsa stain. With M’Fadyean’s 
stain, B. anthracis organisms are square-ended, blue-black 
bacilli surrounded by a pink capsule. In a Gram stain, 
Bacillus anthracis is a large Gram positive rod that may 
occur singly, in pairs or in chains. Endospores are not found 
in host tissues unless they have been exposed to air. 
Antibiotic treatment may result in false negatives. 
Bacterial culture may be used for diagnosis. After 
overnight incubation, B. anthracis colonies on blood agar 
are white or gray, approximately 3-5 mm in diameter, and 
nonhemolytic, with a rough, ground-glass appearance and a 
very tacky, butyrous consistency. Tails – wisps of growth 
trailing back toward the parent colony – may sometimes be 
seen; this characteristic has been described as a “medusa 
head” appearance. Capsules are not found when this 
organism is grown aerobically in vitro, but may be 
demonstrated in mucoid colonies from cultures grown on 
nutrient agar with 0.7% sodium bicarbonate, incubated 
overnight at 37ºC (98.6°F) under CO2. Capsules can also be 
induced by incubating the bacteria in blood for several 
hours. Unlike the other members of the B cereus group, B 
anthracis is non-motile. B. anthracis is susceptible to 
specific bacteriophages (the gamma bacteriophage) and 
exhibits a characteristic ‘string-of-pearls’ formation when 
grown with penicillin; however, the latter characteristics 
may be absent with some isolates. 
In decomposing carcasses, putrefactive bacteria may 
outcompete and eliminate B. anthracis inside the body. In 
this case, anthrax may be confirmed by isolatng the organism 
from soil contaminated by the terminal discharges. However, 
recovery of this organism from decomposed carcasses, 
processed animal products such as bone meal or hides, and 
environmental samples can be difficult, and may require 
specialized laboratory procedures. 
PCR is also used for diagnosis. This technique detects 
the bacterial toxin and capsule genes. Mouse or guinea pig 
inoculation to confirm virulence has largely been replaced 
by PCR; however, animal tests may be considered if other 
tests have failed. Although it has been superceded in many 
locations, some countries use a thermoprecipitin test 
(Ascoli test) to detect thermostable anthrax antigens in 
decomposed carcasses and animal products. Research 
laboratories may use immunofluorescence to detect B. 
anthracis capsules in blood or tissues, but this method is 
not generally used for diagnosis. 
Immunoblotting (Western blotting) and ELISAs are 
available; however, serology is mainly used in research and 
rarely used for diagnosis. A skin hypersensitivity test using 
AnthraxinT is widely used in some countries for the 
retrospective diagnosis of anthrax in animals and humans.  
Treatment 
Antibiotics may be effective if treatment is started 
early. Supportive therapy may also be necessary. 
Prevention 
In endemic areas, modified live vaccines can prevent 
anthrax in livestock. Livestock are vaccinated annually, 
before the season when outbreaks generally occur. 
Livestock vaccines have also been used to protect cheetahs 
and endangered ruminants including black rhinoceros. 
Anthrax is a reportable disease. Quarantines, effective 
carcass disposal techniques, and decontamination can help 
prevent dissemination during outbreaks. Sick animals should 
be isolated. To prevent sporulation, carcasses should not be 
opened. Scavengers should also be prevented from accessing 
the carcass. Local regulations determine carcass disposal; 
however, incineration is considered to be the most effective 
disposal method for carcasses, contaminated manure, 
bedding and other materials. Deep burial may also be used, 
but is less desirable. Barns, pens and equipment should be 
cleaned and disinfected. Once the soil has been contaminated 
by spores, it is very difficult to decontaminate; however, 
procedures such as soil removal and/or treatment with 
formaldehyde may be used in some circumstances. Insect 
repellents help prevent flies from spreading the organism. If a 
pet has been exposed to anthrax, the fur should be 
decontaminated by repeated bathing to mechanically remove 
the organism.  
During an outbreak, prophylactic antibiotics are given 
to exposed and at-risk animals. Prophylactic treatment is 
well understood for outbreaks due to natural causes, but 
prolonged treatment could be necessary in a bioterrorist 
attack with aerosolized spores. Simultaneous vaccination 
and antibiotic treatment are not used in animals, because 
animal vaccines are live. However, animals can be 
vaccinated after antibiotic treatment. Grazing animals 
should be moved away from areas of possible 
contamination, and contaminated feed should be removed. 
Good hygiene should be observed by anyone exposed 
to infected animals or contaminated areas, both to avoid 
spreading the disease and for personal protection. 
Morbidity and Mortality 
The worldwide incidence of anthrax is difficult to 
determine; however, this disease has been reported from 
nearly every continent. Outbreaks occur periodically in 
some countries. These epizootics may be seen in 
domesticated or wild animals, and are typically associated 
with droughts, heavy rains or flooding. Outbreaks are 
uncommon among domesticated animals in developed 
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nations. Approximately 25 outbreaks were reported in the 
U.S. between 1994 and 2000. Sporadic cases occur between 
outbreaks. Sporadic cases of anthrax are reported almost 
every year in domesticated or wild animals in the U.S.; the 
estimated annual mortality rate in U.S. livestock is one 
animal per one million animals at risk. Recently, more 
severe outbreaks have been reported on game ranches with 
non-traditional species, such as white-tailed deer. This may 
be related to difficulties in vaccinating exotic ungulates.  
The mortality rate for anthrax varies with the species. 
Clinical infections in ruminants and horses are usually fatal; 
pigs often recover. In carnivores, mortality is also relatively 
low. Mortality rates are not widely available for wild 
animals; however, in 2004, an outbreak in the Malilangwe 
Wildlife Reserve in Zimbabwe killed almost all of the 
approximately 500 kudu in the reserve, as well as 68% of 
the nyala (Tragelaphus angasi), 48% of the bushbuck 
(Tragelaphus scriptus), 44% of the waterbuck (Kobus 
ellipsiprymnus) and 42% of the roan antelope (Hippotragus 
equinus). Approximately 6% of the buffalo (Syncerus 
caffer) in the area also died. 
Internet Resources 
American College of Physicians. Physicians Information and 
Education Resource (PIER). Anthrax 
http://pier.acponline.org/physicians/public/d892/d892.html  
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/nczved/divisions/dfbmd/ 
CDC Emergency Response and Preparedness: Anthrax 
http://www.bt.cdc.gov/agent/anthrax/  
Food and Agriculture Organization of the United Nations. 
Manual on Meat Inspection for Developing Countries 
http://www.fao.org/docrep/003/t0756e/t0756e00.htm  
Medical Microbiology 
http://www.ncbi.nlm.nih.gov/books/NBK7627/ 
Public Health Agency of Canada.  
Material Safety Data Sheets 
http://www.phac-aspc.gc.ca/msds-ftss/index.html  
Spotts Whitney EA et al. Inactivation of Bacillus anthracis 
spores. 
http://www.cdc.gov/ncidod/eid/vol9no6/02-0377.htm  
The Merck Manual 
http://www.merck.com/pubs/mmanual/  
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp  
World Health Organization. Guidelines for the Surveillance 
and Control of Anthrax in Humans and Animals 
http://www.who.int/csr/resources/publications/anthrax/
WHO_EMC_ZDI_98_6/en/  
World Organization for Animal Health (OIE) 
http://www.oie.int/ 
OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
References 
Animal Health Australia. The National Animal Health Information 
System [NAHIS]. Anthrax [online]. NAHIS; 2001 Oct. 
Available at: http://www.brs.gov.au/usr–
bin/aphb/ahsq?dislist=alpha.* Accessed 19 Nov 2002.  
Avashia SB, Riggins WS, Lindley C, Hoffmaster A, Drumgoole 
R, Nekomoto T, Jackson PJ, Hill KK, Williams K, Lehman L, 
Libal MC, Wilkins PP, Alexander J, Tvaryanas A, Betz T. 
Fatal pneumonia among metalworkers due to inhalation 
exposure to Bacillus cereus containing Bacillus anthracis 
toxin genes. Clin Infect Dis. 2007;44:414-416. 
Binkley CE, Cinti S, Simeone DM, Colletti LM. Bacillus 
anthracis as an agent of bioterrorism: a review emphasizing 
surgical treatment. Ann Surg. 2002;236:9-16. 
Bischof TS, Hahn BL, Sohnle PG. Characteristics of spore 
germination in a mouse model of cutaneous anthrax. J Infect 
Dis. 2007;195:888-894.  
Carter ME, Carter GR, Quinn PJ, Markey BK. Clinical veterinary 
microbiology. London: Mosby; 1994. Bacillus species; p. 178-182. 
Centers for Disease Control and Prevention [CDC]. Anthrax 
[online] CDC;2006 Feb. Available at: 
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/anthrax_t.htm. 
Accessed 22 Feb 2007. 
Centers for Disease Control and Prevention. Advisory Committee 
on Immunization Practices. Use of anthrax vaccine in response 
to terrorism: supplemental recommendations of the Advisory 
Committee on Immunization Practices. JAMA. 
2002;288:2681-2682.  
Clegg SB, Turnbull PC, Foggin CM, Lindeque PM. Massive 
outbreak of anthrax in wildlife in the Malilangwe Wildlife 
Reserve, Zimbabwe. Vet Rec. 2007;160:113-118. 
Fouet A, Smith KL, Keys C, Vaissaire J, Le Doujet C, Levy M, 
Mock M, Keim P. Diversity among French Bacillus anthracis 
isolates. J Clin Microbiol. 2002;40:4732-4734. 
Helgason E., Økstad OA, Caugant DA, Johansen HA, Fouet A, 
Mock M, Hegna I, Kolstø AB. Bacillus anthracis, Bacillus 
cereus, and Bacillus thuringiensis – one species on the basis of 
genetic evidence. Appl Environ Microbiol. 2000;66:2627-2630. 
Herenda D, Chambers PG, Ettriqui A, Seneviratna P, da Silva TJP. 
Manual on meat inspection for developing countries [online]. 
FAO animal production and health paper 119. Publishing and 
Multimedia Service, Information Division, FAO; 1994 
(reprinted 2000). Anthrax. Available at: 
http://www.fao.org/docrep/003/t0756e/T0756E03.htm#ch3.3.8. 
Accessed 21 Feb 2007. 
Hoffmaster AR, Hill KK, Gee JE, Marston CK, De BK, Popovic 
T, Sue D, Wilkins PP, Avashia SB, Drumgoole R, Helma CH, 
Ticknor LO, Okinaka RT, Jackson PJ. Characterization of 
Bacillus cereus isolates associated with fatal pneumonias: 
strains are closely related to Bacillus anthracis and harbor B. 
anthracis virulence genes. J Clin Microbiol. 2006;44:3352-60. 
Anthrax 
Last Updated: March 2007 © 2007 page 8 of 8 
Jernigan J A, Raghunathan PL, Bell BP, Bresnitz RB, Butler JC, 
Cetron M, Cohen M, Doyle R, Greene C, Griffith KS, Guarner 
J, Hadler J, Hayslett JA, Meyer R, Petersen LR, Phillips M, 
Pinner R, Popovic T, Quinn CP, Reefhuis J, Reissman D, 
Rosenstein N, Schuchat A, Shieh W, Siegal L, Swerdlow DL, 
Tenover FC, Traeger M, Ward JW, Weisfuse I, Wiersma S, 
Yeskey K, Zaki S, Ashford DA, Perkins BA, Ostroff S, 
Hughes J, Fleming D, Koplan JP, Gerberding JL. Investigation 
of bioterrorism-related anthrax, United States, 2001: 
epidemiologic findings. Emerg Infect Dis. 2002;8:1019-1028. 
Kahn CM, Line S, editors. The Merck veterinary manual [online]. 
Whitehouse Station, NJ: Merck and Co; 2003. Anthrax. 
Available at: 
http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/b
c/50400.htm Accessed 22 Feb 2007. 
Keim P, Price LB, Klevytska AM, Smith KL, Schupp JM, 
Okinaka R, Jackson P, Hugh-Jones ME. Multiple-locus 
variable-number tandem repeat analysis reveals genetic 
relationships within Bacillus anthracis. J. Bacteriol. 
2000;182:2928-2936. 
Klee SR, Ozel M, Appel B, Boesch C, Ellerbrok H, Jacob D, 
Holland G, Leendertz FH, Pauli G, Grunow R, Nattermann H. 
Characterization of Bacillus anthracis-like bacteria isolated 
from wild great apes from Cote d'Ivoire and Cameroon. J 
Bacteriol. 2006;188:5333-5344. 
Kortepeter M, Christopher G, Cieslak T, Culpepper R, Darling R, 
Pavlin J, Rowe J, McKee K, Eitzen E, editors. Medical 
management of biological casualties handbook [online]. 4th ed. 
United States Department of Defense; 2001. Anthrax. 
Available at: http://www.vnh.org/BIOCASU/6.html.* 
Accessed 19 Nov 2002. 
Langston C. Postexposure management and treatment of anthrax 
in dogs--executive councils of the American Academy of 
Veterinary Pharmacology and Therapeutics and the American 
College of Veterinary Clinical Pharmacology. AAPS J. 
2005;7:E272-3.Leendertz FH, Ellerbrok H, Boesch C, 
Couacy-Hymann E, Matz-Rensing K, Hakenbeck R, 
Bergmann C, Abaza P, Junglen S, Moebius Y, Vigilant L, 
Formenty P, Pauli G. Anthrax kills wild chimpanzees in a 
tropical rainforest. Nature. 2004;430:451-452. 
Little SF.Anthrax vaccines: a development update. BioDrugs. 
2005;19:233-245. 
Luna VA, King DS, Peak KK, Reeves F, Heberlein-Larson L, 
Veguilla W, Heller L, Duncan KE, Cannons AC, Amuso P, 
Cattani J. Bacillus anthracis virulent plasmid pX02 genes 
found in large plasmids of two other Bacillus species. J Clin 
Microbiol. 2006;44:2367-2377. 
Morens DM.Epidemic anthrax in the eighteenth century, the 
Americas. Emerg Infect Dis. 2002;8:1160-1162.  
Okinaka R, Pearson T, Keim P. Anthrax, but not Bacillus 
anthracis? PLoS Pathog. 2006;2:e122. 
Public Health Agency of Canada. Material Safety Data Sheet –
Bacillus anthracis. Office of Laboratory Security; 2001 Jan. 
Available at: http://www.phac-aspc.gc.ca/msds-
ftss/index.html. Accessed 19 Nov 2002. 
Sagripanti JL, Carrera M, Insalaco J, Ziemski M, Rogers J, 
Zandomeni R. Virulent spores of Bacillus anthracis and other 
Bacillus species deposited on solid surfaces have similar 
sensitivity to chemical decontaminants. J Appl Microbiol. 
2007;102:11-21.  
Saile E, Koehler TM. Bacillus anthracis multiplication, 
persistence, and genetic exchange in the rhizosphere of grass 
plants. Appl Environ Microbiol. 2006;72:3168-74. 
Sirisanthana T, Brown AE. Anthrax of the gastrointestinal tract. 
Emerg Infect Dis. 2002;8:649-651. 
Spotts Whitney EA, Beatty ME, Taylor TH Jr, Weyant R, Sobel J, 
Arduino MJ, Ashford DA. Inactivation of Bacillus anthracis 
spores. Emerg Infect Dis. 2003;9:623-627. 
Turnbull PCB. Bacillus. In: Baron S, editor. Medical 
microbiology [online]. 4th ed. New York: Churchill 
Livingstone; 1996. Available at: 
http://www.ncbi.nlm.nih.gov/books/NBK7627/. ** 
Accessed 22 Feb 2007. 
Turnbull PCB. Anthrax. In: Palmer SR, Soulsby EJL, Simpson DIH. 
Zoonoses. New York: Oxford University Press; 1998. p. 3-16. 
Turnbull PC, Tindall BW, Coetzee JD, Conradie CM, Bull RL, 
Lindeque PM, Huebschle OJ. Vaccine-induced protection 
against anthrax in cheetah (Acinonyx jubatus) and black 
rhinoceros (Diceros bicornis). Vaccine. 2004;22:3340-3347. 
United States Department of Agriculture, Animal and Plant Health 
Inspection Service, Veterinary Services [USDA APHIS, VS]. 
Epizootiology and ecology of anthrax [online]. Available at: 
http://www.aphis.usda.gov/vs/ceah/cei/taf/emerginganimalhea
lthissues_files/anthrax.pdf. Accessed 5 Mar 2007. 
Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, 
Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, 
Friedlander AM. Short-course postexposure antibiotic 
prophylaxis combined with vaccination protects against 
experimental inhalational anthrax. Proc Natl Acad Sci U S A. 
2006;103:7813-7816. 
World Organization for Animal Health [OIE] . Manual of 
diagnostic tests and vaccines [online]. Paris: OIE; 2004. 
Anthrax. Available at: http://www.oie.int/international-
standard-setting/terrestrial-manual/access-online/**. Accessed 
22 Feb 2007.  
 
* Link defunct as of 2007 
**Link updated 2012 
